CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74.2% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

Trade Novavax NVAX

Sell
 Buy

Novavax live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2025 Mar 31, 21:34

Health Care Up on Defensive Rotation - Health Care Roundup | Morningstar

Novavax Inc
Trading Central 2025 Mar 31, 21:11

US Market Brief: S&P 500 and Dow Jones Kick Off Week in Positive Fashion

Novavax Inc
Webhose 2025 Mar 31, 17:20

Novavax (NASDAQ:NVAX) Shares Gap Down - Here's Why

Novavax Inc
Webhose 2025 Mar 30, 21:51

Novavax, Inc. (NVAX): Among Top High-Risk, High-Reward Growth Stocks To Buy Now

Novavax Inc
Webhose 2025 Mar 28, 07:31

Swiss National Bank Boosts Stake in Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2025 Mar 24, 06:54

Zacks Research Comments on Novavax FY2027 Earnings

Novavax Inc
Webhose 2025 Mar 19, 18:04

Novavax (NASDAQ:NVAX) Stock Price Down 6.1% - Here's Why

Novavax Inc
Webhose 2025 Mar 16, 08:44

Novavax, Inc. (NASDAQ:NVAX) Receives $18.00 Average Price Target from Brokerages

Novavax Inc
Webhose 2025 Mar 13, 15:25

Novavax call volume above normal and directionally bullish | Markets Insider

Novavax Inc
Webhose 2025 Mar 11, 12:35

Novavax announces Young to retire as Chair of the Board, McGlynn to succeed | Markets Insider

Novavax Inc
Webhose 2025 Mar 11, 12:05

Novavax Names Margaret McGlynn Board Chair, Replacing Young

Novavax Inc
Webhose 2025 Mar 11, 08:16

Novavax Appoints Margaret McGlynn To Succeed James Young As Chair Of The Board

Novavax Inc
Webhose 2025 Mar 08, 17:52

Novavax (NASDAQ:NVAX) Stock Price Up 6.7% - Here's Why

Novavax Inc
Webhose 2025 Mar 06, 09:19

SBI Securities Co. Ltd. Buys Shares of 34,485 Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2025 Mar 03, 06:49

What is Zacks Research's Forecast for Novavax Q1 Earnings?

Novavax Inc

Latest news

Frances Wang 2025 Mar 31, 16:00

Gold Prices Hit New Highs: What is Gold CFD trading?

Commodities
Frances Wang 2025 Mar 31, 16:00

Oil Markets Today: Oil Falls on OPEC+ Output Hike and Trump’s Tariffs

Commodities
Tommy Yap 2025 Mar 29, 16:00

Week Ahead: U.S. Non-Farm Payrolls Coming Up: What to Expect

Forex Indices
Frances Wang 2025 Mar 27, 16:00

Stock market today: S&P 500, Dow, Nasdaq slip on Trump's tariff escalation

Indices
Frances Wang 2025 Mar 27, 16:00

Forex news today: EUR/USD Struggles to Gain Traction Amid Tariff Threats

Forex
Tommy Yap 2025 Mar 27, 16:00

Morning Note: U.K. Retail Sales, U.S. Core PCE & Canada GDP Outlook

Morning Note Forex
Tommy Yap 2025 Mar 26, 16:00

Morning Note: U.S. GDP, Canada Inflation & SEC Crypto-Friendly Plans

Morning Note USD CAD Cryptocurrencies
Frances Wang 2025 Mar 25, 16:00

Central Banks Weigh Interest Rate Moves Amid Inflation Debate

Fed

Info

Spread

0.05

Spread (%)

0.8251 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Tuesday

13:31 - 19:59

Monday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1125910016

Shares Outstanding

160844000

Earnings Date (Next)

2019-05-10

Div Yield

2019-05-10

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-1.23

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments
Trustpilot